FMII
PCRX icon

Farmers & Merchants Investments Inc’s Pacira BioSciences PCRX Stock Holding History

Farmers & Merchants Investments Inc’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$812 Hold
32
– – ﹤0.01% 1573
2026
Q1 		$723 Hold
32
– – ﹤0.01% 1567
2025
Q4 		$828 Hold
32
– – ﹤0.01% 1506
2025
Q3 		$825 Hold
32
– – ﹤0.01% 1530
2025
Q2 		$765 Hold
32
– – ﹤0.01% 1517
2025
Q1 		$795 Hold
32
– – ﹤0.01% 1512
2024
Q4 		$603 Hold
32
– – ﹤0.01% 1611
2024
Q3 		$482 Hold
32
– – ﹤0.01% 1684
2024
Q2 		$916 Hold
32
– – ﹤0.01% 1490
2024
Q1 		$935 Hold
32
– – ﹤0.01% 1456
2023
Q4 		$1.08K Hold
32
– – ﹤0.01% 1416
2023
Q3 		$982 Hold
32
– – ﹤0.01% 1383
2023
Q2 		$1.28K Hold
32
– – ﹤0.01% 1293
2023
Q1 		$1.31K Hold
32
– – ﹤0.01% 1260
2022
Q4 		$1.24K Hold
32
– – ﹤0.01% 1314
2022
Q3 		$2K Buy
+32
New +$1.78K ﹤0.01% 1053
2021
Q3 		– Sell
-38
Closed -$2K – 1054
2021
Q2 		$2K Buy
+38
New +$2.4K ﹤0.01% 893

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Farmers & Merchants Investments Inc's PCRX Position: Q2 2026 in Review

Farmers & Merchants Investments Inc held its Pacira BioSciences (PCRX) position steady in Q2 2026 at 32 shares worth $812. The position accounts for ﹤0.01% of the portfolio, ranked #1573.

Farmers & Merchants Investments Inc first reported a position in PCRX in Q2 2021 and has held it in 17 quarters since. The position peaked at $2K in Q3 2022. 97 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • Farmers & Merchants Investments Inc held 32 shares of Pacira BioSciences worth $812 as of Q2 2026.
  • Farmers & Merchants Investments Inc left its Pacira BioSciences share count unchanged in Q2 2026.
  • Pacira BioSciences made up ﹤0.01% of Farmers & Merchants Investments Inc's portfolio in Q2 2026, its #1573 holding.
  • Farmers & Merchants Investments Inc first reported a position in Pacira BioSciences in Q2 2021 and has held it in 17 quarters since.
  • Farmers & Merchants Investments Inc's Pacira BioSciences position peaked at $2K in Q3 2022.
  • 97 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Farmers & Merchants Investments Inc's 13F filing for Q2 2026, filed 20 Jul 2026.